|
|
||||||||
Ann Thorac Surg 2001;71:1753-1754
© 2001 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Hospital Clínico Universitario de Santiago, Ave Choupana, s/n, 15706 Santiago de Compostela, Spain
b Department of Cardiology, Hospital Clínico Universitario de Santiago, Ave Choupana, s/n, 15706 Santiago de Compostela, Spain
e-mail: alfg{at}vll.servicom.es
To the Editor
We read with interest the article by Albes and colleagues [1]. This excellent article points out that mechanical ventricular assistance is recommended as a therapeutic option for primary cardiac allograft failure, although only a limited number of successful cases have been reported.
We previously reported a case of a patient with a primary graft failure, who recovered with pneumatic biventricular assistance [2]. Our patient was a 41-year-old man who underwent orthotopic heart transplantation. Intraoperative acute allograft failure occurred and required immediate placement of a pneumatic biventricular assist device (Thoratec Laboratories, Berkeley, CA). The mechanical support continued for 49 days until graft recovery resulted in successful weaning.
Primary graft failure after heart transplantation, although uncommon, is associated with high mortality. Increasing experience of heart transplant teams with high recipient pulmonary vascular resistance and use of suboptimal donor hearts may increase intraoperative acute graft failure.
Several questions remain in the management of primary graft failure with biventricular mechanical circulatory support.
First, it is impossible to distinguish between grafts that can be recovered after circulatory assistance and irreversibly damaged hearts.
Second, in patients with right ventricular failure secondary to pulmonary hypertension it may be sufficient to place a right ventricular assistance device. However, use of biventricular support in all cases allows optimal decompression of cardiac cavities and avoids paradoxical movement of the interventricular septum.
Third, the duration ventricular assistance is highly variable and ranges from several hours to many weeks. In our patient weaning was performed on the 49th postoperative day.
Fourth, the patient we reported and that of Albes and associates returned to the operating room after ventricular assist device implantation because of mediastinal bleeding. In addition, convalescence after device explantation was complicated by infection. These experiences show that bleeding and infection remain the most serious complications of ventricular support for intraoperative primary graft failure.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |